DOI: 10.1111/apt.16241 ISSN:

Editorial: anti‐TNF agents against vedolizumab as a second‐line treatment? Not surprising tie game—authors’ reply

Sara Rundquist, Michael C. Sachs, Carl Eriksson, Ola Olén, Scott Montgomery, Jonas Halfvarson
  • Pharmacology (medical)
  • Gastroenterology
  • Hepatology
Show PDF Cite

LINKED CONTENT

This article is linked to Rundquist et al and Roblin et al. papers. To view these articles, visit https://doi.org/10.1111/apt.16193 and https://doi.org/10.1111/apt.16212

More from our Archive